ask="N/A"
ask_size="N/A"
average_daily_volume="1065970"
bid="42.50"
bid_size="100"
book_value="3.62"
change="-2.09"
change_from_200_day_moving_average="-0.33"
change_from_50_day_moving_average="1.52"
change_from_52_week_high="-9.98"
change_From_52_week_low="12.26"
change_in_percent="-4.42%"
close="45.17"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.63"
ebitda="-145.92M"
eps_estimate_current_year="-2.34"
eps_estimate_next_quarter="-0.63"
eps_estimate_next_year="-1.30"
ex_dividend_date="N/A"
float_shares="85906000"
high="47.19"
high_52_weeks="55.15"
last_trade_date="3/16/2017"
last_trade_price="45.17"
last_trade_size="28135"
last_trade_time="4:00pm"
low="45.16"
low_52_weeks="32.91"
market_capitalization="3.93B"
moving_average_200_day="45.50"
moving_average_50_day="43.65"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="67.67"
open="47.19"
pe_ratio="N/A"
peg_ratio="0.53"
percent_change_from_200_day_moving_average="-0.72%"
percent_change_from_50_day_moving_average="+3.48%"
percent_change_from_52_week_high="-18.10%"
percent_change_from_52_week_low="+37.25%"
previous_close="47.26"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="13.04"
price_per_sales="274.47"
revenue="15.00M"
shares_outstanding="87114000"
short_ratio="4.06"
stock_exchange="NMS"
symbol="NBIX"
volume="822301"
weeks_range_52="32.91 - 55.15"
